Novel 3+1 mixed-ligand Technetium-99m complexes carrying dipeptides as monodentate ligands

Nuclear Medicine and Biology

Volumn 31, Issue 1, 2004, Pages 139-146

  Fernandes, Célia ^a   Patrício, Luciana ^a   Moreira, Rui ^b   Cantinho, Guilhermina ^c   Pena, Helena ^c   Campello, Paula C ^a   Santos, Isabel ^a  

^a INSTITUTO TECNOLÓGICO E NUCLEAR   (Portugal)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

3+1 approach; 99mTc; Biodistribution studies; Dipeptides; Re

Indexed keywords

ALANYLGLYCINE; DIPEPTIDE DERIVATIVE; GLYCINE DERIVATIVE; GLYCYLGLYCINE; PEPTIDE; PHENYLALANYLGLYCINE; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; REDUCING AGENT; RHENIUM COMPLEX; TARTARIC ACID; TECHNETIUM 99M; TECHNETIUM COMPLEX; TIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; HEPATOBILIARY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IONIZATION; ISOTOPE LABELING; LIPOPHILICITY; LIVER; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRECURSOR; RAT;

EID: 1642492860     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(03)00129-X     Document Type: Article

References (23)

1. 3 and Biodistribution of By-products. Int J Appl Rad Isot. 39:1988;121-129.
2. Brenner D., Davison A., Lister-James J., Jones A.G. Synthesis and characterization of a series of isomeric oxotechnetium(v) diamido dithiolates. Inorg Chem. 23:1984;3793-3797.
3. Fietz T., Spies H., Pietzch H.-J., Leibnitz P. Synthesis and molecular structure of chloro(3-thiapentane-1,5-dithiolato)oxorhenium(V). Inorg Chim Acta. 231:1995;233-236.
4. Freeman L.M., Lan J.A. Radiopharmaceutical evaluation of the hepatobiliary pathway. Nucl Med Biol. 17:1990;129-139.
5. 3 as a Hippuran Replacement. J Nucl Med. 27:1986;111-116.
6. Hom R.K., Katzenellenbogen J.A. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals recent developments and encouraging results . Nucl Med Biol. 24:1997;485-498.
7. Johannsen B., Pietzsch H.-J. Development of Technetium-99m-based CNS receptor ligands have there been any advances? Eur J Nucl Med. 29:2002;263-275.
8. 2A serotonin receptor binding structure-affinity considerations . Nucl Med Biol. 23:1996;429-438.
9. Jurisson S.S., Lydon J.D. Potential technetium small molecule radiopharmaceuticals. Chem Rev. 99:1999;2205-2218.
10. 99mTc-labeled small peptides as diagnostic radiopharmaceuticals. Chem Rev. 99:1999;2235-2268.
11. Loberg M.D., Fields A. Chemical structure of technetium-99m-labeled N-(2,6-dimethylphenylcarbamoylmethyl)-iminodiacetic acid (Tc-HIDA). Int J Appl Rad Isot. 29:1978;167-173.
12. Mastrostamis S.G., Papadopoulos M.S., Pirmettis I.C., Paschali E., Varvarigou A.D., Stassinopoulou C.I., Raptopoulou C.P., Terzis A., Chiotellis E. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents. J Med Chem. 37:1994;3212-3218.
13. 99mTc complex as a dopamine transporter imaging agent. J Am Chem Soc. 117:1995;11037-11038.
14. nd ed. 1970;Wiley-Interscience, New York. Ch. 3-9.
15. Nunn A.D. Radiopharmaceuticals. Chemistry and pharmacology. 1992;Marcel Dekker, Inc, New York.
16. Pietzch H.-J., Spies H., Hoffmann S. Lipophilic technetium complexes VI. Neutral oxotechnetium(V) complexes with monothiole/tridentate dithiole coordination. Inorg Chim Acta. 165:1989;163-166.
17. 99mTc aminobisthiolato/monothiolato "3 + 1" mixed ligand complexes structure-activity relationships and preliminary in vivo validation as brain blood flow imaging agents . J Med Chem. 40:1997;2539-2549.
18. Pirmettis I.C., Patsis G., Pelecanou M., Tsoukalas C., Papadopoulos A., Raptopoulou C.P., Terzis A., Papadopoulos M., Chiotellis E. Synthesis of oxorhenium(V) and oxotechnetium(V) [SN(R)S/S] mixed ligand complexes containing a phenothiazine moiety on the tridentate SN(R)S ligand. Bioorg Med Chem Lett. 11:2001;1859-1862.
19. 99mTc(V) complexes with SH group-containing proteins. Appl Radiat Isot. 54:2001;637-644.
20. Spies H., Fietz T., Pietzch H.-J., Johannsen B., Leibnitz P., Reck G., Scheller D., Klostermann K. Neutral oxorhenium(V) complexes with tridentate dithiolates and monodentate alkane- or arene-thiolate coligands. J Chem Soc Dalton Trans. 1995;2277-2280.
21. Spies H, Pietzch HJ, Johannsen B. The "n + 1" mixed-ligand approach in the design of specific technetium radiopharmaceuticals: potencials and problems. in: technetium, rhenium and other metals in chemistry and nuclear medicine, Padova, 1999; Vol. 5, pp. 101-108.
22. Ullrich KJ. Membrane Transporters as Drug Targets. Amidon GL, Sadée W, eds. Kluwer Academic/Plenum, New York, 1999, p. 159.
23. Nugent W.A., Mayer J.M. Metal-ligand multiple bonds. 1998;Wiley- Interscience, Wiley & Sons, New York.